Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
OSR-C52H8 | Canine | Canis lupus OSMR beta Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
|
OSR-H52H9 | Human | Human OSMR beta Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
|
OSR-C52H9 | Cynomolgus | Cynomolgus OSMR beta Protein, His Tag (MALS verified) | ![]() |
![]() ![]() |
The purity of Canis lupus OSMR beta Protein, His Tag (Cat. No. OSR-C52H8) is more than 90% and the molecular weight of this protein is around 105-125 kDa verified by SEC-MALS.
The purity of Human OSMR, His Tag (Cat. No. OSR-H52H9) is more than 85% and the molecular weight of this protein is around 105-125 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Vixarelimab | RO-7622888; RG-6536; KPL-716; BIIB-069 | Phase 2 Clinical | Biogen Inc | Pruritus; Chronic Urticaria; Psoriasis; Prurigo; Lichen Planus; Neurodermatitis; Colitis, Ulcerative | Details |
Vixarelimab | RO-7622888; RG-6536; KPL-716; BIIB-069 | Phase 2 Clinical | Biogen Inc | Pruritus; Chronic Urticaria; Psoriasis; Prurigo; Lichen Planus; Neurodermatitis; Colitis, Ulcerative | Details |
This web search service is supported by Google Inc.